These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37546064)

  • 21. Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013-17.
    Allahyari A; Jernberg T; Lautsch D; Lundman P; Hagström E; Schubert J; Boggs R; Salomonsson S; Ueda P
    Eur Heart J Qual Care Clin Outcomes; 2021 Jan; 7(1):59-67. PubMed ID: 32142112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment practices and lipid profile of patients with acute coronary syndrome: results from a tertiary care hospital.
    Farmakis I; Zafeiropoulos S; Kartas A; Boulmpou A; Nevras V; Papadimitriou I; Tampaki A; Vlachou A; Markidis E; Koutsakis A; Ziakas A; Karvounis H; Giannakoulas G
    Acta Cardiol; 2020 Oct; 75(6):527-534. PubMed ID: 31219734
    [No Abstract]   [Full Text] [Related]  

  • 23. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
    Kawada-Watanabe E; Ogawa H; Koyanagi R; Arashi H; Yamaguchi J; Matsui K; Hagiwara N
    J Cardiol; 2017 Mar; 69(3):536-541. PubMed ID: 27349705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missed Opportunities in Implementation and Optimization of Lipid-Lowering Therapies in Very-High-Risk Patients Presenting with ST-Segment Elevation Myocardial Infarction.
    Kopp K; Motloch L; Berezin A; Maringgele V; Ostapenko H; Mirna M; Schmutzler L; Dieplinger A; Hoppe UC; Lichtenauer M
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of post-myocardial infarction lipid levels and management: Results from a tertiary care hospital of Pakistan.
    Rauf R; Soomro MI; Khan MN; Kumar M; Soomro NA; Kazmi KA
    World J Cardiol; 2024 May; 16(5):282-292. PubMed ID: 38817645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-density lipoprotein cholesterol goal attainment among post myocardial infarction patients on lipid lowering therapy at Siriraj outpatient clinic.
    Praipaisarnkit K; Wongpraparut N; Pongakasira R
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S147-54. PubMed ID: 24772592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial.
    Zhao SP; Yu BL; Peng DQ; Huo Y
    Atherosclerosis; 2014 Apr; 233(2):707-712. PubMed ID: 24603217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program.
    Nowowiejska-Wiewióra A; Wita K; Mędrala Z; Tomkiewicz-Pająk L; Bujak K; Mizia-Stec K; Brzychczy P; Gąsior M; Gąsior Z; Kulbat A; Kalarus Z; Wojakowski W; Trzeciak P; Witkowski A; Banach M; Legutko J
    Kardiol Pol; 2023; 81(4):359-365. PubMed ID: 36871294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction.
    Qureshi N; Antoniou S; Cornel JH; Schiele F; Perrone-Filardi P; Brachmann J; Sidelnikov E; Villa G; Ferguson S; Rowlands C; González-Juanatey JR
    Adv Ther; 2023 Jan; 40(1):233-251. PubMed ID: 36289145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prehospital statin use and low-density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project.
    Xing Y; Liu J; Hao Y; Liu J; Huo Y; Smith SC; Ge J; Ma C; Han Y; Fonarow GC; Taubert KA; Morgan L; Yang N; Zhou M; Zhao D;
    Am Heart J; 2019 Jun; 212():120-128. PubMed ID: 30986750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
    Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (studie IMPROVE-IT)].
    Špinar J; Špinarová L; Vítovec J
    Vnitr Lek; 2014 Dec; 60(12):1095-101. PubMed ID: 25692840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa.
    Pitso L; Mofokeng TRP; Nel R
    BMC Endocr Disord; 2021 Aug; 21(1):159. PubMed ID: 34365977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dyslipidaemia management in the cardiac rehabilitation clinic of a tertiary referral centre: analysis of the impact of new ESC guidance on LDL-C target achievement.
    McCaughey C; Ranganathan D; Kerins M; Murphy G; Murphy R
    Ir J Med Sci; 2022 Dec; 191(6):2569-2577. PubMed ID: 35031936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
    Singh A; Gupta A; Collins BL; Qamar A; Monda KL; Biery D; Lopez JAG; de Ferranti SD; Plutzky J; Cannon CP; Januzzi JL; Di Carli MF; Nasir K; Bhatt DL; Blankstein R
    J Am Coll Cardiol; 2019 May; 73(19):2439-2450. PubMed ID: 31097165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncontrolled hyperlipidemia in Chinese patients who experienced acute coronary syndrome: an observational study.
    Jiang J; Zhou YJ; Li JJ; Ge JB; Feng YQ; Huo Y;
    Ther Clin Risk Manag; 2018; 14():2255-2264. PubMed ID: 30532548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice.
    Sabouret P; Puymirat E; Kownator S; Abdennbi K; Lebeau F; Meltz M; Angoulvant D; Schiele F
    Panminerva Med; 2023 Jun; 65(2):244-249. PubMed ID: 36222543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.